This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove topic audits-and-inspections
article thumbnail

Pharmaceutical microbiology: key developments 2022

European Pharmaceutical Review

JANUARY 16, 2023

Another major topic covered by the experts was technological advances. Changes may be needed, such as improved corporate culture, information management, retraining of personnel, and upgraded facilities, suggested Cundell. He questioned how regulators will enforce revisions to Good Manufacturing Practice (GMP) regulations.

Pharmaceutical 125
Pharmaceutical Food and Drug Administration Manufacturing FDA 125
article thumbnail

The Brazilian pharma market: Key information and what may change

Pharmaceutical Technology

DECEMBER 9, 2022

Before the recent change in administration at the 2022 Presidential Election, Brazil’s health regulatory agency Anvisa had recently joined the Pharmaceutical Inspection Co-operation Scheme (PIC/S) in 2020, introducing new processes that would allow product owners to launch products in the national market with greater ease.

Marketing 98
Marketing Pharma Pharmaceutical Healthcare 98
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024